Myelin Repair Discovery Step Forward in Search to Stop MS
MS Society
PR-M02-22-12Feb 14, 2022
Virus
New Insights into Virus Evasion Tactics
Pharma's Almanac
PAO-M00-19-NI-003Sep 04, 2019
Research
Researchers Discover Potential Cause for Alzheimer’s Disease
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-028Nov 28, 2018
Research
Newfound Mechanism May Yield Ways to Counter Mistaken Immune Attack on Body
NYU Langone Health
PR-M11-18-NI-097Nov 28, 2018
CRISPR
CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next
Nigel Walker
Nice Insight
PAO-M08-18-NI-030Aug 29, 2018
Clinical Data
Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719
Nice Insight
PAO-M08-18-NI-028Aug 29, 2018
FDA Approval
AbbVie Receives FDA Approval for IMBRUVICA® Plus Rituximab as a Blood Cancer Treatment
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-18-NI-027Aug 29, 2018
Research
A Key to the Cage: Opening the Living Membrane Gate
National University of Science and Technology MISiS
PR-M06-18-NI-066Jun 20, 2018
GMP
State-of-the-Art Biologics Manufacturing in an Unexpected Location
Vladas Algirdas Bumelis
Northway Biotechpharma
PAP-Q2-18-CL-010May 29, 2018
Next-Generation Drug Development
Challenges for Next-Generation Biological Therapeutics in Discovery and Development
Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch
Nice Insight
PAP-Q2-18-FA-001May 29, 2018
Fill-Finish Services
Providing Flexible Capabilities to Meet Market Demand for Sterile Fill-Finish Services
Andrea Baiocchi
Avara Pharmaceutical Services
PAP-Q2-18-CL-020May 29, 2018
Drug Discovery
TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date
Guy Tiene
Nice Insight
PAO-M05-18-NI-020May 29, 2018
Discovery
A New Landscape: M&A in the Discovery & Research Sector
Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch
Nice Insight
PAP-Q1-18-NI-002Mar 12, 2018
Biologics
Fully Supporting Customer Needs for Biologics Development and Manufacturing
Samsung Biologics
PAP-Q1-18-CL-016Mar 12, 2018
Innovation
Single-Pill, HIV-1 Combination Therapy Approved
Nice Insight
PAO-M11-17-NI-050Nov 30, 2017
Discovery
Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration
Nice Insight
PAO-M11-17-NI-049Nov 30, 2017
FDA Approval
Advanced Follicular Lymphoma Treatment Approved
Nice Insight
PAO-M11-17-NI-048Nov 28, 2017
Gene Editing
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
Nice Insight
PAO-M11-17-NI-046Nov 28, 2017
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
Emilie Branch
Pharma's Almanac
PAO-M11-17-NI-036Nov 21, 2017
Acquisition
Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy
Nice Insight
PAO-M11-17-NI-020Nov 10, 2017